{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:10:37Z","timestamp":1787602237704,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korea Health Technology Research and Development Project"},{"name":"Ministry of Health & Welfare, Republic of KOREA","award":["A111345"],"award-info":[{"award-number":["A111345"]}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2012M2A2A7014020"],"award-info":[{"award-number":["2012M2A2A7014020"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2009-0078234"],"award-info":[{"award-number":["NRF-2009-0078234"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ygyno.2014.12.032","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T00:22:55Z","timestamp":1420590175000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Quantitative metabolic parameters measured on F-18 FDG PET\/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer"],"prefix":"10.1016","volume":"136","author":[{"given":"Choon-Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Oh","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaetae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.12.032_bb0005","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/GRF.0b013e31824b9bc5","article-title":"A rational approach to the management of recurrent or persistent ovarian carcinoma","volume":"55","author":"Thigpen","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/bjc.2011.364","article-title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","volume":"105","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2013.06.020","article-title":"Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors","volume":"131","author":"Petrillo","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2014.05.029","article-title":"Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis","volume":"134","author":"Petrillo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2014.09.017","article-title":"Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial","volume":"136","author":"Lee","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0035","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer","volume":"19","author":"Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0040","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00259-014-2803-x","article-title":"The role of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET\/CT in the prognosis of epithelial ovarian cancer","volume":"41","author":"Lee","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00259-013-2610-9","article-title":"Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer","volume":"41","author":"Ebina","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2014.12.032_bb0050","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2014.12.032_bb0065","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00259-014-2688-8","article-title":"Metabolic tumour burden assessed by 18F-FDG PET\/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection","volume":"41","author":"Xu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0075","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","article-title":"Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma","volume":"40","author":"Kim","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/RLU.0b013e31829f57fa","article-title":"Prognostic predictive value of total lesion glycolysis from 18F-FDG PET\/CT in post-surgical patients with epithelial ovarian cancer","volume":"38","author":"Liao","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0085","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"2","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","article-title":"Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort","volume":"105","author":"Zang","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00259-011-2059-7","article-title":"Whole-body metabolic tumour volume of 18F-FDG PET\/CT improves the prediction of prognosis in small cell lung cancer","volume":"39","author":"Oh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2014.12.032_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3348\/kjr.2013.14.1.1","article-title":"Prognostic significance of volume-based PET parameters in cancer patients","volume":"14","author":"Moon","year":"2013","journal-title":"Korean J Radiol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814016308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814016308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:36:27Z","timestamp":1758771387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814016308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0090825814016308"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative metabolic parameters measured on F-18 FDG PET\/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}